Dry eye is a chronic syndrome and is a progressive depending upon the cause and severity. It is a condition when a person does not have tears to lubricate his or her eyes. Tears are an essential part of maintaining good health of the eye and assist in providing good vision. The syndrome is commonly seen among older people and is becoming common among people spending a long time in front of the computer. The factors that can cause dry eye include age, medications, environmental conditions, long term use of contact lenses. The conditions cannot be cured completely; however, it can be managed by using medical products.
Allergan PLC (Abbvie), and Alcon – Notable Market Players in Dry Eye Product Market
Market leaders operating in the market have undertaken various organic growth strategies in the dry eye product market. The dry eye product market majorly consists of the players such as Novartis AG; Santen Pharmaceutical Co., Ltd; Johnson and Johnson Services, Inc; OASIS Medical; URSAPHARM Arzneimittel GmbH; ROHTO Pharmaceutical Co.,Ltd; OCuSOFT Inc; Bausch Health Companies Inc; AbbVie Inc; and Prestige Consumer Healthcare Inc. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the companies have utilized inorganic strategies including mergers & acquisitions, partnership, and collaborations.
Below is the list of the growth strategies done by the players operating in the dry eye product market:
| Year | News |
| Jan-20 | Santen Pharmaceutical Co., Ltd as a part of its business expansion in China has decided to construct its second plant for its Chinese subsidiary “Santen Pharmaceutical (China) Co., Ltd.” to support the growing demand for products in China. |
| Jun-20 | OCuSOFT Inc. and EKKDA Research, LLC entered into a sales-distribution agreement. This partnership help the partners to establish and develop in ophthalmology and optometry related business. EKKDA’s research LLC’s projects are focused fundamentally on eye care. |
| May-20 | AbbVie Inc. acquired Allergan plc as a part of company’s inorganic business strategy. The acquisition has provided the company access to and expand its business portfolio in the eye care associated markets. |
